Clinical Cancer Research
Collection
Collection
- ISSN: 10780432
Published by AACR - American Association for Cancer Research, Philadelphia (PA)
-
Disposition of chremophor EL in humans limits the potential for modulation of the multidrug resistance phenotype in vivo Article
Clinical Cancer Research, 1937-1942.A. Sparreboom (Alex), J. Verweij (Jaap), M.E.L. van der Burg (Maria), W.J. Loos (Walter), E. Brouwer (Eric), L. Viganò (Lucia), A. Locatelli (Alberta), A.I. de Vos (Aad), K. Nooter (Kees), G. Stoter (Gerrit), et al. L. Gianni (Luca)
August 1998 -
A comparison of clinical pharmacodynamics of different administration schedules of oral topotecan (Hycamtin) Article
Clinical Cancer ResearchC.J.H. Gerrits, I. Hudson, J. Verweij (Jaap), D.D. Von Hoff (Daniel), J.H.M. Schellens (Jan), H. Burris (Howard), J.R. Eckardt, A.S.Th. Planting (André), M.E.L. van der Burg (Maria), G.I. Rodriguez, et al. W.J. Loos (Walter) and V.M. van Beurden (Vera)
January 1999
-
Drug-administration sequence does not change pharmacodynamics and kinetics of irinotecan and cisplatin Article
Clinical Cancer ResearchM.J.A. de Jonge (Maja), J. Verweij (Jaap), A.S.Th. Planting (André), M.E.L. van der Burg (Maria), G. Stoter (Gerrit), M. de Boer-Dennert (Maureen), P.J. de Bruijn (Peter), E. Brouwer (Eric), L. Vernillet and A. Sparreboom (Alex)
January 1999
-
Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma Article
Clinical Cancer ResearchM.A.I. Ghanem (Mazen), Th.H. van der Kwast (Theo), J.C. den Hollander (Jan), M.K. Sudaryo, M.H.A. Oomen (Monique), M.A. Noordzij (Marinus), M.M. van den Heuvel-Eibrink (Marry), S.M. Nassef, R.J.M. Nijman (Rien) and G.J. van Steenbrugge (Gert Jan)
January 2000
-
Inter- and intrapatient variability in oral topotecan pharmacokinetics: implications for body-surface area dosage regimens Article
Clinical Cancer ResearchW.J. Loos (Walter), A.J. Gelderblom (Hans), A. Sparreboom (Alex), J. Verweij (Jaap) and M.J.A. de Jonge (Maja)
January 2000
-
Factors involved in prolongation of the terminal disposition phase of SN-38: clinical and experimental studies Article
Clinical Cancer ResearchD.F.S. Kehrer (Diederik), W. Yamamoto, J. Verweij (Jaap), M.J.A. de Jonge (Maja), P.J. de Bruijn (Peter) and A. Sparreboom (Alex)
January 2000
-
Role of intestinal P-glycoprotein in the plasma and fecal disposition of docetaxel in humans Article
Clinical Cancer ResearchC. van Zuylen (Lia), J. Verweij (Jaap), K. Nooter (Kees), E. Brouwer (Eric), G. Stoter (Gerrit) and A. Sparreboom (Alex)
January 2000
-
The orally administered P-glycoprotein inhibitor R101933 does not alter the plasma pharmacokinetics of docetaxel Article
Clinical Cancer ResearchC. van Zuylen (Lia), A. Sparreboom (Alex), A. van der Gaast (Ate), M.E.L. van der Burg (Maria), V.M. van Beurden (Vera), C.J. Bol, R. Woestenborghs, P.A. Palmer and J. Verweij (Jaap)
January 2000